Placebo use and unblinding in COVID-19 vaccine trials: recommendations of a WHO Expert Working Group

The WHO ACT-Accelerator Ethics & Governance Working Group

doi:10.1038/s41591-021-01299-5

Placebo use and unblinding in COVID-19 vaccine trials: recommendations of a WHO Expert Working Group

The WHO ACT-Accelerator Ethics & Governance Working Group

Department of Philosophy and Classics

University of KwaZulu-Natal
University of Toronto
University of Washington
Global Healthcare Consulting
Oxford University
Yenepoya University
University of Pennsylvania
Johns Hopkins University
Tribhuvan University
Universidade Federal de Minas Gerais
The University of Hong Kong
Graduate Institute
University of Tehran
Institut Pasteur de Dakar
Universidade Federal de São Paulo
Western University

Research output: Contribution to journal › Letter › peer-review

10 Citations (Scopus)

Original language	English
Pages (from-to)	569-570
Number of pages	2
Journal	Nature Medicine
Volume	27
Issue number	4
DOIs	https://doi.org/10.1038/s41591-021-01299-5
Publication status	Published - Apr 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1038/s41591-021-01299-5

Cite this

@article{4fcf11b1e8434c6583173cd6391b8596,

title = "Placebo use and unblinding in COVID-19 vaccine trials: recommendations of a WHO Expert Working Group",

author = "\{The WHO ACT-Accelerator Ethics \& Governance Working Group\} and Singh, \{Jerome Amir\} and Sonali Kochhar and Jonathan Wolff and Caesar Atuire and Anant Bhan and Ezekiel Emanuel and Ruth Faden and Prakash Ghimire and Dirceu Greco and Calvin Ho and Suerie Moon and Ehsan Shamsi-Gooshki and Aissatou Tour{\'e} and Beatriz Thom{\'e} and Smith, \{Maxwell J.\} and Upshur, \{Ross E.G.\}",

year = "2021",

month = apr,

doi = "10.1038/s41591-021-01299-5",

language = "English",

volume = "27",

pages = "569--570",

journal = "Nature Medicine",

issn = "1078-8956",

publisher = "Nature Research",

number = "4",

}

TY - JOUR

T1 - Placebo use and unblinding in COVID-19 vaccine trials

T2 - recommendations of a WHO Expert Working Group

AU - The WHO ACT-Accelerator Ethics & Governance Working Group

AU - Singh, Jerome Amir

AU - Kochhar, Sonali

AU - Wolff, Jonathan

AU - Atuire, Caesar

AU - Bhan, Anant

AU - Emanuel, Ezekiel

AU - Faden, Ruth

AU - Ghimire, Prakash

AU - Greco, Dirceu

AU - Ho, Calvin

AU - Moon, Suerie

AU - Shamsi-Gooshki, Ehsan

AU - Touré, Aissatou

AU - Thomé, Beatriz

AU - Smith, Maxwell J.

AU - Upshur, Ross E.G.

PY - 2021/4

Y1 - 2021/4

UR - https://www.scopus.com/pages/publications/85102862030

U2 - 10.1038/s41591-021-01299-5

DO - 10.1038/s41591-021-01299-5

M3 - Letter

C2 - 33727699

AN - SCOPUS:85102862030

SN - 1078-8956

VL - 27

SP - 569

EP - 570

JO - Nature Medicine

JF - Nature Medicine

IS - 4

ER -

Placebo use and unblinding in COVID-19 vaccine trials: recommendations of a WHO Expert Working Group

UN SDGs

Access to Document

Other files and links

Cite this